Non-Ambulatory SCI Walk Using a Robotic Exoskeleton: Effect on Bone and Muscle
1 other identifier
interventional
13
1 country
1
Brief Summary
The purpose of this research study is to evaluate an exoskeleton device and mobility skills in the device.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2013
CompletedFirst Submitted
Initial submission to the registry
December 3, 2014
CompletedFirst Posted
Study publicly available on registry
December 24, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2018
CompletedMarch 22, 2017
March 1, 2017
4.2 years
December 3, 2014
March 20, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bilateral Muscle Volume (surrogate for strength)for thigh and shank will be the primary outcome measurement.
To examine the effectiveness of exoskeleton assisted overground walking (5 hours per week, 100 sessions, 20 weeks = 100 hours) to induce positive changes in muscle volume and structure of the lower limbs for non-ambulatory persons with SCI.
100 hours
Secondary Outcomes (1)
Muscle Activation
100 hours
Study Arms (1)
Exoskeleton training
EXPERIMENTALTo examine the effectiveness of robotic exoskeleton-assisted over ground walking (5 hrs. p/wk, 100 sessions, 20 wks = 100 hrs) to induce positive changes in muscle volume and structure of the lower limbs for non-ambulatory persons with SCI. Combined with our current training protocol where people step 1500-2000/session we predict that the 2,000 lower extremity muscle contractions will be sufficient in our proposed exoskeletal study. MRI's will be performed to accurately assess muscle CSA of each lower limb to determine individual's muscle thigh and shank volume. Muscle Biopsies for the quadricep muscle will be performed to determine changes in BMD and bone structure due to intensive exoskeleton assisted walking.
Interventions
Exoskeleton Training (100 sessions - 1 hour, 4 - 5 sessions per week for 20 weeks) to enhance functional ambulation for persons with a spinal cord injury. To examine the effectiveness of exoskeleton assisted overground walking to induce positive changes in muscle volume and structure of the lower limbs for non-ambulatory persons with SCI.
Needle Biopsies for Quadricep Muscles will be performed to define changes in BMD and Bone structure with intensive exoskeleton assisted walking. This procedure includes having a trained physician make a small skin incision, after numbing the area over the muscle, and then removing a tiny sliver of muscle to study under the microscope. Three separate biopsies for one incision will be obtained. The biopsies will be performed at baseline, 7 days, and after the intervention. To define changes in biochemical markers of bone metabolism with intensive exoskeleton-assisted walking.
MRI's will provide accurate assessments of muscle CSA of each lower limb (from above the origin of the iliopsoas to the insertion of the achilles tendon) to determine individual's muscle thigh and shank volume.
Eligibility Criteria
You may qualify if:
- Must be a non walker with a SCI greater than 1 year post injury
- Must have a neurological level between the C6-T10 level
- Must have a lower extremity score greater than 1 as defined by the neurological exam
- Must be between 21 and 45 years old
- Must be wheelchair reliant 100% of time
- Must have knee bone mineral density greater than .5755 gm/cm2 as determined by study staff
- Must have a score on the Modified Ashworth Scale equal to or less than 3 as determined by the study staff
- Must be able to tolerate upright standing for up to 30 minutes
- Must have joint range of motion within normal functional limits for ambulation
- Must have sufficient upper body strength to balance using the walker while wearing the exoskeleton
- Must have a height between 62 inches or 74 inches
- Must weigh less than 220 lbs,(limitation of the devices)
- Must have no joint tightening of any extremity that limits movement during walking with the assistive devices
- Must have no medical issue that precludes full weight bearing, ambulation or exercise intolerance in the exoskeleton (e.g. orthopedic injuries, pain, severe spasticity)
- Must have no skin issues (e.g. pressure sores) that would prevent wearing the device
- +3 more criteria
You may not qualify if:
- A woman who is pregnant, lactating, or post-menopausal
- Wearing an external device that supports the spinal column or the head, neck, or trunk
- Have persistent orthostatic hypotension (blood pressure drop of more than 30 millimeters of Mercury in robotic system)
- Have had a hospitalization for heart attack, heart surgery or acute heart failure within 3 months of enrollment in study or no presence of major cardiovascular or pulmonary disease, lower extremity deep vein thrombosis (within the last three months)
- Have been taking any medications known to influence bone metabolism
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kessler Foundationlead
- New Jersey Commission on Spinal Cord Researchcollaborator
Study Sites (1)
Kessler Foundation
West Orange, New Jersey, 07052, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gail F Forrest, PhD
Kessler Foundation
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 3, 2014
First Posted
December 24, 2014
Study Start
October 1, 2013
Primary Completion
December 1, 2017
Study Completion
March 1, 2018
Last Updated
March 22, 2017
Record last verified: 2017-03
Data Sharing
- IPD Sharing
- Will share